Adicet Bio, Inc · 8 hours ago
SENIOR ACCOUNTS PAYABLE SPECIALIST – PART-TIME CONTRACTOR
Adicet Bio, Inc. is a clinical stage biotechnology company focused on developing gamma delta T cell therapies for autoimmune diseases and cancer. The Senior Accounts Payable Specialist will be responsible for the full cycle accounts payable process, ensuring compliance with GAAP and corporate policies while supporting the accounting team in a fast-paced environment.
BiopharmaBiotechnologyHealth CareMedical
Responsibilities
Ensure all vendor invoices are booked and allocated accurately with sufficient evidence in compliance with GAAP and company policy
Process two-way and three-way match of invoices in CorPay in paperless environment
Ensure proper documentation is attached to invoices for approval, payment authorization and auditing purposes
Research and partner with employees and vendors to resolve invoice and purchase order discrepancies
Correspond with vendors regarding invoices, payments, and other finance-related inquiries
Reconcile vendor statements
Support accurate and timely completion of A/P month, quarter, and year-end close. This includes reviewing monthly vendor statements, open POs, accruals, and reconciling goods received but not invoiced (GRNI)
Assist with weekly processing of cash disbursements, including preparation of ACH and wire batches
Support interim and year-end audit process (internal and external)
Collaborate with Procurement Department to maintain an accurate and up-to-date vendor database ensuring all vendor documentation and tax forms are current
Assist in the preparation of annual 1099 reporting to IRS. Ensure vendors are properly flagged in CorPay and Microsoft Dynamics Business Central
Identify and escalate priority issues timely with management
Handle tax-related matters and support compliance with local, state, and federal regulations
Assist A/P Manager in generating and maintaining various reports, including vendor aging reports, payment analysis, and month-end closing reports
Review A/P Aging Report and weekly payment batch reports to monitor outstanding balances and ensure timely processing
Other tasks as assigned
Qualification
Required
Bachelor's Degree in Accounting, Finance or Business Administration
Minimum of five years A/P experience
High attention to detail and accuracy
Ability to be organized and manage multiple projects while exemplifying stellar interpersonal skills
Excellent communication skills (oral and written)
Proficiency with Microsoft Office (Outlook, Word & Excel) and Acrobat DC
Ability to work with high volume of transactions in a fast-paced environment
An aptitude for learning and managing ERP data structures and reporting capabilities
Results and goal-oriented mindset with an opportunistic eye towards process improvements
Strong ability to prioritize and organize work
Agility to adjust quickly to new priorities
Ability to collaborate and communicate effectively
Preferred
Experience with CorPay and Microsoft Dynamics Business Central is a plus
Benefits
Base salary
Annual cash bonus
Long-term incentives (equity)
Employee Stock Purchase Plan (ESPP)
401(k) with ROTH and a 4.5% Company match
Comprehensive health plans (medical, dental, vision, etc.)
Flexible Health and Commuter Spending Accounts (FSA)
Company matched Health Savings Account (HSA)
Life, AD&D, short and long-term disability insurance
Legal, pet, and various other voluntary insurance programs
Generous paid time-off including 13 company holidays
Paid end-of-year winter break
Vacation
Sick time
Paid parental leave
Onsite gym and various other fitness options
Onsite parking with electric vehicle charging stations
Free shuttle (Caltrain)
Company-subsidized lunches (delivered onsite daily)
Fully stocked breakrooms
Company
Adicet Bio, Inc
At Adicet (Nasdaq: ACET), we are defined by our mission to deliver best-in-class gamma-delta T cell therapies for patients fighting autoimmune diseases and cancer.
Funding
Current Stage
Public CompanyTotal Funding
$424.23MKey Investors
OrbiMed
2025-10-07Post Ipo Equity· $80M
2024-01-22Post Ipo Equity· $98M
2022-08-08Post Ipo Equity
Recent News
2026-01-07
2026-01-06
2025-12-26
Company data provided by crunchbase